Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 4
Submit an article Journal homepage
153
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up

Emilia ScalzulliDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Gioia ColafigliDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Sara PepeDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Giulia De LucaDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Alessio Di PrimaDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Fabio EfficaceDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Daniela DiverioDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Roberto LatagliataDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Maurizio MartelliDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Robin FoàDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
&
Massimo BrecciaDepartment of Translational and Precision Medicine, Sapienza University, Rome, ItalyCorrespondence[email protected]
 show all
Pages 1026-1027 | Received 18 Apr 2020, Accepted 04 Aug 2020, Published online: 16 Aug 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up." Leukemia & Lymphoma, 62(4), pp. 1026–1027

Author contributions

ES, MB the manuscript wrote and analyze the data; GC and DD performed molecular analyses; SP, GDL, ADP, RL followed patients and collected data; FE, MM and RF revised the final paper.

Disclosure statement

MB received honoraria from Novartis, Pfizer, Incyte. All the other authors have no conflict of interests.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.